Notably, accumulating evidence suggests that cAMP signaling can strongly suppress the activity of CDK1 mainly owing to the phosphorylation of Cdc25B and subsequent phosphorylation of CDK1 in various cell types, including melanoma cells [14,28,29]. The gene discussed is CDK1; the disease is melanoma.